892243-35-5 (IPR-803 | Ser/Thr Protease,3-[[12-(Azepan-1-yl)-8-oxo-15-oxa-14-azatetracyclo[7.6.1.02,7.013,16]hexadeca-1(16),2,4,6,9,11,13-heptaen-10-yl]amino]benzoic acid)

BDBM50401173;3-[3-(Hexahydro-1H-azepine-1-yl)-6-oxo-6H-anthra[1,9-cd]isoxazole-5-ylamino]benzoic acid;3-[[12-(Azepan-1-yl)-8-oxo-15-oxa-14-azatetracyclo[7.6.1.02,7.013,16]hexadeca-1(16),2,4,6,9,11,13-he;IPR-803;3-[[3-(Hexahydro-1H-azepin-1-yl)-6-oxo-6H-anthra[1,9-cd]isoxazol-5-yl]amino]benzoic acid (ACI);IPR 803;G13848;HY-111192;IPR803;AKOS001777289;GLXC-03142;CHEMBL2206359;3-[[12-(Azepan-1-yl)-8-oxo-15-oxa-14-azatetracyclo[7.6.1.02,7.013,16]hexadeca-1(16),2,4,6,9,11,13-heptaen-10-yl]amino]benzoic acid;SCHEMBL12499325;3-((3-(Azepan-1-yl)-6-oxo-6H-anthra[1,9-cd]isoxazol-5-yl)amino)benzoic acid;3-{[3-(1-AZEPANYL)-6-OXO-6H-ANTHRA[1,9-CD]ISOXAZOL-5-YL]AMINO}BENZOIC ACID;CS-0034598;892243-35-5;MS-28247;

UAEULQWANHYLGJ-UHFFFAOYSA-N

1S/C27H23N3O4/c31-25-18-10-3-4-11-19(18)26-23-22(25)20(28-17-9-7-8-16(14-17)27(32)33)15-21(24(23)29-34-26)30-12-5-1-2-6-13-30/h3-4,7-11,14-15,28H,1-2,5-6,12-13H2,(H,32,33)

O1C2C3C=CC=CC=3C(C3=C(C=C(C(C3=2)=N1)N1CCCCCC1)NC1C=CC=C(C(=O)O)C=1)=O